Question 1

What is Insight Molecular Diagnostics Inc. (IMDX) stock price today?

Accepted Answer

Insight Molecular Diagnostics Inc. (IMDX) currently trades at $3.83 per share. The stock has a market capitalization of $123.53M and a P/E ratio of —x.

Question 2

Is IMDX stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Insight Molecular Diagnostics Inc. has a Smart Value Score of 17/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is Insight Molecular Diagnostics Inc.'s revenue and earnings?

Accepted Answer

Insight Molecular Diagnostics Inc. has trailing twelve-month (TTM) revenue of $4.05M with profit margins of 0.00%. Earnings per share (EPS) is $-1.65.

Question 4

Is IMDX stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, Insight Molecular Diagnostics Inc.'s intrinsic value is $4.60, representing a margin of safety of -24.57%. The stock currently trades at a P/E of —x.

Metric	2022	2023	2024	2025	TTM
Revenue	$958000.00	$1.50M	$1.88M	$4.05M	$4.05M
Net income	$-72.90M	$-27.78M	$-60.66M	$-50.22M	$-22.95M
EPS	—	—	—	—	$-1.65
Free cash flow	$-49.91M	$-23.61M	$-21.23M	$-25.37M	$-7.02M
Profit margin	-7,609.81%	-1,848.37%	-3,225.04%	-1,238.52%	—

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
IMDX	$123.53M	17	5.3	2.5	4.0	5.0	-24.57%	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Insight Molecular Diagnostics Inc.

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare